Clinical use1.1 Indications1.2 Combination with diureticIrbesartan is also available in a combination formulation with a low dose thiazide diuretic, invariably hydrochlorothiazide, to achieve an additive reduccion de dosis de avapro effect. Irbesartan/hydrochlorothiazide combination preparations are marketed.

N Engl reduccion de dosis de avapro Med 345 (12): 851-60. reduccion de dosis de avapro 11565517.^ Rossi S, editor. Australian reduccion de dosis de avapro Handbook; 2006. ISBN 0-9757919-2-3 IrbesartanFrom Wikipedia, the reduccion de dosis de avapro encyclopedia(Redirected from Avapro)Jump to: navigation, searchIrbesartanSystematic (IUPAC) name2-butyl-3-[p-(o-1H-tetrazol-5-ylphenyl)benzyl]-1,3-diazaspiro[4.4]non-1-en-4-oneIdentifiersCAS number 138402-11-6ATC code C09CA04PubChem 3749DrugBank APRD00413Chemical dataFormula C25H28N6OMol. mass 428.53SMILES eMolecules & PubChemPharmacokinetic dataBioavailability reduccion de dosis de avapro Hepatic (CYP2C9)Half life 11–15 hoursExcretion Renal 20%, faecal 65%Therapeutic considerationsLicence data EU, USPregnancy cat. D (Au)Legal status S4 (Au), POM (UK), ?-only (U.S.)Routes OralIrbesartan (INN) (pronounced reduccion de dosis de avapro is an angiotensin II receptor antagonists, irbesartan is indicated for the treatment of hypertension. Irbesartan was developed by Sanofi Research (now part of sanofi-aventis). It is jointly marketed by sanofi-aventis and Bristol-Myers Squibb.

with nephropathy due to type 2 diabetes.". N Engl J Med 345 reduccion de dosis de avapro 851-60. PMID 11565517.^ Rossi PMID.